MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) has announced initial test results of its mustard-derived organic biopesticide formulation designed to control Fusarium wilt TR4, a destructive pathogen threatening the global banana industry, which is valued at $25 billion. Completed via third-party independent laboratory CyberAgrot SAS in Colombia, the testing reported 100% control Fusarium wilt TR4, known as Panama disease. The disease led to the declaration of a national state of emergency in Colombia in 2019. Based on what the company has been able to determine, complete control of this disease has never been achieved. The company is now planning more advanced testing of the product in greenhouse and field settings, which could lead to registration and use in Colombia and other countries that produce bananas. Following ICA official protocols, samples treated with MustGrow’s natural organic biopesticide showed 100% control of Fusarium wilt TR4 while control samples the didn’t use the biopesticide showed Fusarium wilt TR4 growing. “The CyberAgrot team is very pleased with the recent laboratory results of MustGrow’s mustard-derived product,” said CyberAgrot general manager Alexander Chajin Robles in the press release. “This work further advances MustGrow towards our shared goal of combating the Panama Disease, which has devastated the Banana Industry in Colombia and across the globe. Eliminating the disease is a national priority for the Colombian government, with the disease now affecting acres in many regions of Colombia. MustGrow’s product achieved 100% control of Fusarium wilt TR4 and we very much look forward to now begin field trials. With further success, we will advance conversations with the Colombian Agriculture regulatory body as well as the Colombian Banana Association, accelerating MustGrow’s product as the only 100% organic solution to a growing crisis.”
To view the full press release, visit https://ibn.fm/OfDWy
About MustGrow Biologics Corp.
MustGrow is a publicly traded, agriculture biotech company focused on providing natural, science-based biological solutions for high-value crops, including fruits and vegetables. MustGrow has designed and owns a U.S. EPA-approved natural solution that uses the mustard seed’s natural defense mechanism to protect plants from pests and diseases. Over 110 independent tests have been completed, validating MustGrow’s safe and effective signature products. The product, in granule format, is EPA-approved across all key U.S. states and by Health Canada’s Pest Management Regulatory Agency (“PMRA”) as a biopesticide for high-value crops, including fruits and vegetables. MustGrow has now concentrated a liquid format, TerraMG, that with regulatory approval could be applied through standard drip or spray equipment, improving functionality and performance features. The company has approximately 37 million basic common shares issued and outstanding. For more information about the company, please visit www.MustGrow.ca.
NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at https://ibn.fm/MGROF
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
InvestorWire is part of the InvestorBrandNetwork.